5 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| BIOGEN MA INC. | 4 |
| Ionis Pharmaceuticals, Inc. | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18283526 | TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | BIOGEN MA INC. | MCKILLOP, JOHN CHARLES | 1637 | Non-Final OA | Sep 22, 2023 |
| 18273053 | MICROTUBULE DESTABILIZER ADDITIVES TO INCREASE RECOMBINANT VIRAL VECTOR TITERS | BIOGEN MA INC. | GRIZER, CASSANDRA SENN | 1672 | Non-Final OA | Jul 19, 2023 |
| 18026772 | COMPOSITIONS AND METHODS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS) WITH AAV-MIR-SOD1 | BIOGEN MA INC. | MCLEOD, AFRICA MHAIRIE | 1635 | Non-Final OA | Mar 16, 2023 |
| 17635363 | COMBINATION THERAPY FOR SPINAL MUSCULAR ATROPHY | BIOGEN MA INC. | MCKILLOP, JOHN CHARLES | 1637 | Non-Final OA | Feb 14, 2022 |
| 17291199 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AMYOTROPHIC LATERAL SCLEROSIS | Ionis Pharmaceuticals, Inc. | QIAN, CELINE X | 1637 | Non-Final OA | May 04, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial